RT Journal Article
SR Electronic
T1 FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005780
DO 10.1136/jitc-2022-005780
VO 10
IS 11
A1 Choueiri, Toni K
A1 Kluger, Harriet
A1 George, Saby
A1 Tykodi, Scott S
A1 Kuzel, Timothy M
A1 Perets, Ruth
A1 Nair, Suresh
A1 Procopio, Giuseppe
A1 Carducci, Michael A
A1 Castonguay, Vincent
A1 Folefac, Edmund
A1 Lee, Chung-Han
A1 Hotte, Sebastien J.
A1 Miller,, Wilson H
A1 Saggi, Shruti Shally
A1 Lee, Chung-Wei
A1 Desilva, Heshani
A1 Bhagavatheeswaran, Prabhu
A1 Motzer, Robert J
A1 Escudier, Bernard
YR 2022
UL http://jitc.bmj.com/content/10/11/e005780.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.